Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
1.610
+0.010 (0.63%)
At close: Jul 26, 2024, 3:57 PM
1.590
-0.020 (-1.24%)
After-hours: Jul 26, 2024, 7:38 PM EDT

Alterity Therapeutics Revenue

Alterity Therapeutics had revenue of 1.90M AUD in the half year ending December 31, 2023, a decrease of -19.43%. This brings the company's revenue in the last twelve months to 3.43M, down -33.38% year-over-year. In the fiscal year ending June 30, 2023, Alterity Therapeutics had annual revenue of 3.92M, down -23.56%.

Revenue (ttm)
3.43M AUD
Revenue Growth
-33.38%
P/S Ratio
n/a
Revenue / Employee
311,929 AUD
Employees
11
Market Cap
14.28M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20233.92M-1.21M-23.56%
Jun 30, 20225.12M783.93K18.06%
Jun 30, 20214.34M--
Jun 30, 2020---
Jun 30, 20194.95M1.83M58.40%
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Jun 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition